← All stocks

HCW Biologics Inc.

HCWB Net buying
CIK 0001828673 #5479 in the set updated 18 Sep 2026
Bought (120 mo)
$11.52M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$11.52M
+$11.52M against sales at will

By person

10 insiders · 99 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Wong Hing C
Chief Executive Officer
$7.87M (21)
+$7.87M
125,845
$325.31K
GARRETT SCOTT T
Director
$1.51M (5)
+$1.51M
192,149
$496.71K
Byam Rebecca
Chief Financial Officer
$1.46M (31)
+$1.46M
57,245
$147.98K
Flowers Lee
SVP of Business Development
$415.59K (7)
+$415.59K
8,691
$22.47K
Rhode Peter
See Remarks
$100.00K (1)
+$100.00K
77,500
$200.34K
+126.0%
Winer Gary M
Director
$89.26K (18)
+$89.26K
4,075
$10.53K
Greene Rick S.
Director
$49.87K (3)
+$49.87K
2,066
$5.34K
Jiao Jin-an
VP of Development
$24.15K (1)
+$24.15K
45,141
$116.69K
+119.4%
Giles Lisa M.
Director
35,815
$92.58K
+35,715%
Medmira Capital Ltd. entity
10% owner
0
$0.00

No percentages here. This company's share count has moved by a factor of 24.5 over the window, from 1,836,324 to 44,934,120 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Rhode Peter
11 Dec 2023
See Remarks
Exercised, kept
14,000
$0.14
$1.96K
Flowers Lee
8 Dec 2023
SVP of Business Development
Exercised, kept
7,501
$0.14
$1.05K
Rhode Peter
17 Nov 2023
See Remarks
Exercised, kept
15,000
$0.14
$2.10K
Byam Rebecca
19 Oct 2023
Chief Financial Officer
Exercised, kept
47,249
$0.14
$6.61K
Flowers Lee
8 Jun 2023
SVP of Business Development
Exercised, kept
5,356
$0.14
$749.84
Byam Rebecca
2 Nov 2022
Chief Financial Officer
Exercised, kept
33,750
$0.14
$4.73K
Jiao Jin-an
31 May 2022
VP of Development
Exercised, kept
1,714
$0.21
$359.94
Jiao Jin-an
31 May 2022
VP of Development
Exercised, kept
12,856
$0.14
$1.80K
Rhode Peter
14 Jan 2022
See Remarks
Exercised, kept
1
$0.14
$0.14
Rhode Peter
14 Jan 2022
See Remarks
Exercised, kept
1,714
$0.21
$359.94
Flowers Lee
1 Dec 2021
SVP of Business Development
Exercised, kept
4,285
$0.14
$599.90
Byam Rebecca
23 Nov 2021
Chief Financial Officer
Exercised, kept
27,000
$0.14
$3.78K

What was left out

Form 4 filings counted 94
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 19,473,868
History held since 23 Jul 2021